Litcius/Paper detail

OA20.02 Pre-Treatment Levels of ctDNA for Long-Term Survival Prediction in Stage IIIA NSCLC Treated With Neoadjuvant Chemo-Immunotherapy

Atocha Romero, Ernest Nadal, Roquinna Serna, Amelia Insa, M.R. García Campelo, C. Garcia Benito, Manuel Dómine, Margarita Majem, Delvys Rodríguez‐Abreu, Alex Martínez‐Martí, J. De Castro, Manuel Cobo, Guillermo López-Vivanco, E. del Barco, Reyes Bernabé, Núria Viñolas, I. Barneto, Santiago Viteri, E. Pereira, Ana Royuela, Marta Casarrubios, Virginia Calvo, R. Laza - Briviesca, Bartomeu Massutí, A. Cruz, Estela Sánchez‐Herrero, Mariano Provencio

2021Journal of Thoracic Oncology20 citationsDOIOpen Access PDF

Topics & Concepts

ChemoimmunotherapyMedicineOncologyInternal medicineStage (stratigraphy)ImmunotherapyNeoadjuvant therapyLung cancerCancerBreast cancerPaleontologyBiologyCancer Genomics and DiagnosticsLung Cancer Diagnosis and TreatmentLung Cancer Treatments and Mutations
OA20.02 Pre-Treatment Levels of ctDNA for Long-Term Survival Prediction in Stage IIIA NSCLC Treated With Neoadjuvant Chemo-Immunotherapy | Litcius